Skip to main content

Table 4 Percentage of dogs with clinical signs associated with flea allergy dermatitis dosed orally with Simparica Trio™ or afoxolaner

From: Safety and efficacy of a novel oral chewable combination tablet containing sarolaner, moxidectin and pyrantel (Simparica Trio™) against natural flea infestations in client-owned dogs in the USA

 

Assessment daya

n

Pruritus

Papules

Erythema

Scaling

Alopecia from self-trauma

Dermatitis/Pyodermatitis

Simparica Trio™

0

127

45.7

18.9

35.4

26.0

33.1

28.3

30

121

19.0

5.8

15.7

16.5

24.8

14.0

60

116

6.9

2.6

7.8

8.6

8.6

3.4

Afoxolaner

0

66

47.0

21.2

31.8

28.8

24.2

31.8

30

63

15.9

3.2

12.7

7.9

22.2

14.3

60

61

6.6

1.6

6.6

6.6

14.8

4.9

  1. aDay 0 = pre-treatment; Day 30 = Days 26 to 35; Day 60 = Days 54 to 66